Structures by: Pandiarajan K.
Total: 27
T(3),t(5)-Dimethyl N-nitroso-r(2),c(6)-bis(o-chlorophenyl)piperidine-4-one oxime.
C19H19Cl2N3O2
Acta Crystallographica Section E (2005) 61, 12 o3987-o3989
a=7.9168(7)Å b=8.5941(8)Å c=14.1572(13)Å
α=90.225(2)° β=101.459(2)° γ=94.810(2)°
T-3-Methyl-1-nitroso-r-2,c-6-diphenylpiperidin-4-one oxime monohydrate
C18H19N3O2,H2O
Acta Crystallographica Section E (2005) 61, 12 o4348-o4350
a=7.9578(13)Å b=7.0567(12)Å c=15.642(3)Å
α=90.00° β=100.483(3)° γ=90.00°
R-2,c-6-Bis(4-chlorophenyl)-t-3,t-5-dimethyl-1-nitrosopiperidin-4-one oxime
C19H19Cl2N3O2
Acta Crystallographica Section E (2005) 61, 12 o4345-o4347
a=12.3909(9)Å b=11.1670(8)Å c=14.1980(10)Å
α=90.00° β=100.9910(10)° γ=90.00°
C-5-Hydroxy-r-2,c-4-bis(isopropoxycarbonyl)-t-5-methyl-t-3-phenylcyclohexanone
C21H28O6
Acta Crystallographica Section E (2006) 62, 2 o703-o705
a=35.775(6)Å b=5.7948(10)Å c=20.174(3)Å
α=90.00° β=99.893(3)° γ=90.00°
3,t-6-Dihydroxy-t-5-methoxycarbonyl-c-6-methyl-r-4-phenyl-4,5,6,7-tetrahydro- 1H-indazole
C16H18N2O4
Acta Crystallographica Section E (2006) 62, 2 o656-o658
a=9.3871(4)Å b=14.7295(6)Å c=21.6478(9)Å
α=90.00° β=90.00° γ=90.00°
Ethyl (E)-2-benzoyl-3-phenylpropenoate
C18H16O3
Acta Crystallographica Section E (2006) 62, 2 o708-o710
a=10.8099(8)Å b=7.2746(5)Å c=18.5285(13)Å
α=90.00° β=94.3260(10)° γ=90.00°
Cis-2-(p-Fluoro)phenyl-6-phenyldithian-4-one 1-oxide
C17H14FO2S
Acta Crystallographica Section E (2007) 63, 11 o4486-o4486
a=11.3887(5)Å b=24.6558(14)Å c=5.1828(2)Å
α=90° β=90° γ=90°
2,6-Diphenylthiapyran-4-one
C17H16O1S1
Acta Crystallographica Section C (2003) 59, 11 o620-o621
a=5.909(2)Å b=9.706(3)Å c=13.184(5)Å
α=102.02(3)° β=94.39(3)° γ=106.39(3)°
2,6-diphenyl-thiopyran-4-one
C17H16OS
Acta Crystallographica Section C (2000) 56, 7 870-871
a=10.867(3)Å b=24.284(4)Å c=5.427(2)Å
α=90.00° β=90.00° γ=90.00°
Dihydropyrimidine
C14H16N2O2S
Acta Crystallographica Section E (2009) 65, 12 o3036
a=12.0415(2)Å b=6.22190(10)Å c=18.0192(3)Å
α=90° β=100.9010(10)° γ=90°
Dihydropyrimidine
C13H13ClN2OS
Acta Crystallographica Section E (2009) 65, 12 o3068
a=7.2346(12)Å b=22.585(3)Å c=8.0941(15)Å
α=90° β=106.177(17)° γ=90°
Piperidin-4-one
C18H19NOS2,H2O
Acta Crystallographica Section E (2009) 65, 4 o885
a=7.5781(7)Å b=10.9926(9)Å c=11.5304(10)Å
α=79.531(2)° β=83.404(2)° γ=71.673(2)°
Dihydropyrazine
C23H20N2
Acta Crystallographica Section E (2009) 65, 3 o546
a=10.4406(10)Å b=10.5753(7)Å c=11.0810(13)Å
α=93.439(8)° β=114.161(10)° γ=118.343(9)°
Thiopyran-4-one 1-oxide
C17H15ClO2S
Acta Crystallographica Section E (2008) 64, 12 o2367
a=11.5195(5)Å b=25.7589(12)Å c=5.2248(2)Å
α=90° β=90° γ=90°
Dihydropyrimidine-2(1H)-thione
C13H13ClN2OS
Acta Crystallographica Section E (2009) 65, 3 o564-o565
a=7.2389(6)Å b=8.2304(7)Å c=12.9038(11)Å
α=73.366(7)° β=89.373(7)° γ=72.613(7)°
Dihydropyrimidinone
C14H16N2O3
Acta Crystallographica Section E (2009) 65, 1 o23
a=23.7948(12)Å b=7.9905(3)Å c=14.4757(7)Å
α=90° β=108.305(5)° γ=90°
Piperidin-4-one
C22H19NOS2
Acta Crystallographica Section E (2011) 67, 3 o571
a=6.1809(3)Å b=12.7391(9)Å c=12.9251(7)Å
α=112.657(6)° β=95.845(5)° γ=98.512(5)°
Dihydropyrimidinone
C13H13ClN2O2
Acta Crystallographica Section E (2008) 64, 12 o2474-o2475
a=14.5364(8)Å b=12.1587(5)Å c=7.0780(4)Å
α=90° β=90° γ=90°
Cyclohex-2-enone
C21H19ClO3
Acta Crystallographica Section E (2009) 65, 1 o191
a=8.0115(3)Å b=11.3525(4)Å c=11.6386(4)Å
α=62.261(2)° β=77.975(2)° γ=75.297(2)°
Cyclohex-2-enone
C21H19BrO3
Acta Crystallographica Section E (2010) 66, 8 o1896
a=11.0138(2)Å b=13.8197(4)Å c=12.1477(3)Å
α=90° β=95.180(2)° γ=90°
Dihydropyrimidin-2(1H)-thione
C13H14N2OS
Acta Crystallographica Section E (2010) 66, 9 o2280
a=7.8849(10)Å b=7.2054(5)Å c=21.555(3)Å
α=90° β=94.401(12)° γ=90°
Piperidine
C25H26N4O
Acta Crystallographica Section E (2010) 66, 11 o2841
a=6.21280(10)Å b=12.8346(3)Å c=15.0022(3)Å
α=65.2930(10)° β=78.8230(10)° γ=86.9480(10)°
1-Acetyl-2-r,6-c-bis(4-chlorophenyl)-3-methyl-1,2,5,6-tetrahydropyridin-4-yl acetate
C22H21Cl2NO3
Acta Crystallographica Section E (2010) 66, 12 o3259
a=16.560(3)Å b=14.809(3)Å c=10.241(2)Å
α=90.00° β=124.27(3)° γ=90.00°
2,3-dihydropyrazine
C23H19ClN2
Acta Crystallographica Section E (2011) 67, 10 o2598
a=10.5675(8)Å b=19.7014(9)Å c=10.4207(7)Å
α=90° β=118.479(9)° γ=90°
<i>c</i>-5-Hydroxy-<i>r</i>-2,<i>c</i>-4-bis(methoxycarbonyl)- <i>t</i>-5-methyl-<i>t</i>-3-(3-nitrophenyl)cyclohexanone
C17H19NO8
Acta Crystallographica Section E (2012) 68, 7 o2213
a=20.1842(18)Å b=5.7380(5)Å c=15.5771(14)Å
α=90.00° β=108.3570(10)° γ=90.00°
Propan-2-yl <i>r</i>-4-(4-fluorophenyl)-3-hydroxy-<i>c</i>-6-methyl-2-phenyl- 4,5-dihydro-2<i>H</i>-indazole-<i>t</i>-5-carboxylate
C24H23FN2O3
Acta Crystallographica Section E (2012) 68, 10 o3021-o3022
a=17.6400(10)Å b=11.0295(6)Å c=11.3791(6)Å
α=90.00° β=99.1330(10)° γ=90.00°
Triphenylpyrazine
C22H16N2
Acta Crystallographica Section E (2009) 65, 1 o106
a=15.563(2)Å b=6.2005(9)Å c=16.845(3)Å
α=90° β=90° γ=90°